MOREPEN LAB. LTD (MOREPENLAB) financials

MOREPEN LAB. LTD (MOREPENLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.[1]

Market Cap: ₹6,788Cr.
Current Price: ₹124
Stock P/E: 61.1
ROE: 5.34%
ROCE: 7.65%
Book Value: ₹22.7
Dividend Yield: 0.16%
52W High / Low: ₹151/33.0

In Jun 2026, MOREPEN LAB. LTD (MOREPENLAB) reported sales ₹541 Cr and net profit ₹54 Cr.

Annual TTM: sales ₹1,831 Cr, net profit ₹112 Cr.

Shareholding: Promoters 35.66% (Sep 2026), FIIs 3.43% (Sep 2026), DIIs 1.70% (Sep 2026), Government 0.01% (Sep 2026), Public 59.19% (Sep 2026).

MOREPENLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	384	403	382	391	370	458	463	541
Expenses	341	372	352	372	342	416	440	461
Operating Profit	43	32	30	19	28	42	23	80
OPM %	11%	8%	8%	4.8%	8%	9%	5%	15%
Other Income	5	5	3	4	6	4	9	5
Interest	1	1	4	4	4	4	4	5
Depreciation	4	5	12	8	11	10	1	8
Profit before tax	43	30	17	11	19	31	28	72
Tax %	26%	25%	31%	29%	24%	25%	27%	25%
Net Profit	32	23	12	8	14	24	20	54
EPS in Rs	0.58	0.41	0.22	0.15	0.26	0.43	0.37	0.99
Raw PDF	—	—	—	—	—	—	—	—

MOREPENLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	792	1,112	1,449	1,339	1,538	1,555	1,681	1,831
Expenses	728	1,000	1,320	1,262	1,376	1,401	1,569	1,658
Operating Profit	64	112	129	77	162	153	112	173
OPM %	8%	10%	9%	6%	11%	10%	7%	9%
Other Income	9	12	10	6	13	16	23	24
Interest	2	2	-7	2	4	7	16	17
Depreciation	34	28	21	18	22	24	29	29
Profit before tax	37	94	126	63	149	138	89	150
Tax %	14%	0%	20%	27%	26%	26%	26%	—
Net Profit	32	94	101	46	111	102	66	112
EPS in Rs	0.72	2.10	2.11	0.90	2.17	1.85	1.21	2.05
Dividend Payout %	0%	0%	0%	0%	0%	11%	17%	—

MOREPENLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	90	90	90	96	102	102	110	110
Reserves	188	217	355	503	678	787	1,072	1,133
Borrowings	139	142	17	19	25	28	96	205
Other Liabilities	203	212	385	417	300	362	444	460
Total Liabilities	619	662	848	1,033	1,106	1,279	1,721	1,908
Fixed Assets	153	135	144	156	171	217	366	403
CWIP	0	0	2	14	17	24	28	8
Investments	118	119	119	118	118	126	205	110
Other Assets	349	408	583	745	800	912	1,122	1,387
Total Assets	619	662	848	1,033	1,106	1,279	1,721	1,908

MOREPENLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	15	11	49	-69	-102	77	29	20
Cash from Investing Activity	-10	-12	-69	-23	-36	-84	-280	-119
Cash from Financing Activity	-0	5	47	66	144	0	260	97
Net Cash Flow	4	3	28	-25	6	-6	9	-1
Free Cash Flow	6	-6	10	-114	-138	2	-149	-114
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	22%	25%	44%	-34%	-111%	71%	42%	40%

MOREPENLAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	35.66%	35.66%	35.66%	35.66%	35.66%	35.66%	35.66%	35.66%
FIIs	2.22%	1.94%	1.72%	1.62%	1.62%	1.59%	1.46%	3.43%
DIIs	1.64%	1.67%	1.50%	1.49%	1.25%	1.25%	1.28%	1.70%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	60.46%	60.72%	61.09%	61.22%	61.46%	61.50%	61.59%	59.19%
No. of Shareholders	4,48,361	4,68,860	4,61,180	4,61,853	4,53,137	4,47,286	4,34,912	4,03,932

MOREPENLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	62	56	51	56	70	75	69	72
Inventory Days	71	93	84	95	85	85	107	88
Days Payable	123	111	95	80	86	103	127	81
Cash Conversion Cycle	10	38	40	71	69	57	50	79
Working Capital Days	-35	-9	16	58	105	104	122	110
ROCE %	8%	9%	21%	22%	9%	18%	13%	8%

MOREPENLABUpdated 18 Oct 2026, 5:58

Morepen Lab. Ltd

MOREPENLABUpdated 18 Oct 2026, 5:58

Market Cap

₹6,788Cr.

Current Price

₹124

High / Low

₹151/33.0

Stock P/E

61.1

ROE5.34%

ROCE7.65%

Book Value₹22.7

Face Value₹2.00

Dividend Yield0.16%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	369	0	344	2	5	22	27	16	0.31
Sep 2023	381	0	352	3	5	27	27	20	0.39
Dec 2023	395	2	344	4	6	47	25	35	0.69
Mar 2024	393	1	336	4	7	53	24	40	0.78
Jun 2024	386	1	337	3	4	47	26	35	0.69
Sep 2024	384	1	341	5	4	43	26	32	0.58
Dec 2024	403	1	372	5	5	30	25	23	0.41
Mar 2025	382	4	352	3	12	17	31	12	0.22
Jun 2025	391	4	372	4	8	11	29	8	0.15
Sep 2025	370	4	342	6	11	19	24	14	0.26
Dec 2025	458	4	416	4	10	31	25	24	0.43
Mar 2026	463	4	440	9	1	28	27	20	0.37
Jun 2026	541	5	461	5	8	72	25	54	0.99

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	370	9	324	1	39	1	19	1	0.01
Mar 2016	452	10	388	-3	35	16	-1	16	0.35
Mar 2017	548	7	487	4	34	23	0	23	0.52
Mar 2018	561	4	501	4	33	26	0	26	0.58
Mar 2019	717	2	652	4	38	29	0	29	0.64
Mar 2020	792	2	728	9	34	37	14	32	0.72
Mar 2021	1112	2	1000	12	28	94	0	94	2.1
Mar 2022	1449	-7	1320	10	21	126	20	101	2.11
Mar 2023	1339	2	1262	6	18	63	27	46	0.9
Mar 2024	1538	4	1376	13	22	149	26	111	2.17
Mar 2025	1555	7	1401	16	24	138	26	102	1.85
Mar 2026	1681	16	1569	23	29	89	26	66	1.21
TTM	1831	17	1658	24	29	150	—	112	2.05

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	35.66%
FIIs	3.43%
DIIs	1.7%
Government	0.01%
Public	59.19%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	38.22%	2.11%	2.21%	0.01%	57.46%
Mar 2024	38.22%	1.85%	2.15%	0.01%	57.76%
Jun 2024	38.22%	1.67%	2.14%	0.01%	57.96%
Sep 2024	35.66%	2.08%	1.69%	0.01%	60.57%
Dec 2024	35.66%	2.22%	1.64%	0.01%	60.46%
Mar 2025	35.66%	1.94%	1.67%	0.01%	60.72%
Jun 2025	35.66%	1.72%	1.5%	0.01%	61.09%
Sep 2025	35.66%	1.62%	1.49%	0.01%	61.22%
Dec 2025	35.66%	1.62%	1.25%	0.01%	61.46%
Mar 2026	35.66%	1.59%	1.25%	0.01%	61.5%
Jun 2026	35.66%	1.46%	1.28%	0.01%	61.59%
Sep 2026	35.66%	3.43%	1.7%	0.01%	59.19%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	90	103	200	106	500	244	0	118	138	500
Mar 2016	90	119	186	139	535	216	0	118	201	535
Mar 2017	90	134	168	155	548	191	0	118	239	548
Mar 2018	90	161	134	206	591	182	0	118	291	591
Mar 2019	90	188	139	203	619	153	0	118	349	619
Mar 2020	90	217	142	212	662	135	0	119	408	662
Mar 2021	90	355	17	385	848	144	2	119	583	848
Mar 2022	96	503	19	417	1033	156	14	118	745	1033
Mar 2023	102	678	25	300	1106	171	17	118	800	1106
Mar 2024	102	787	28	362	1279	217	24	126	912	1279
Mar 2025	110	1072	96	444	1721	366	28	205	1122	1721
Mar 2026	110	1133	205	460	1908	403	8	110	1387	1908

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	51	-30	-20	1
Mar 2016	50	-27	-28	-5
Mar 2017	49	-15	-31	3
Mar 2018	61	-24	-38	-1
Mar 2019	15	-10	0	4
Mar 2020	11	-12	5	3
Mar 2021	49	-69	47	28
Mar 2022	-69	-23	66	-25
Mar 2023	-102	-36	144	6
Mar 2024	77	-84	0	-6
Mar 2025	29	-280	260	9
Mar 2026	20	-119	97	-1

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	48	65	55	72	62	56	51	56	70	75	69	72
Inventory Days	56	53	68	79	71	93	84	95	85	85	107	88
Days Payable	124	140	126	176	123	111	95	80	86	103	127	81
Cash Conversion Cycle	-21	-22	-3	-25	10	38	40	71	69	57	50	79
Working Capital Days	-18	-6	-91	-66	-35	-9	16	58	105	104	122	110
ROCE %	2%	8%	8%	8%	8%	9%	21%	22%	9%	18%	13%	8%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MOREPEN LAB. LTD (MOREPENLAB)?

The reported market capitalisation for MOREPEN LAB. LTD (MOREPENLAB) is ₹6,788Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MOREPENLAB?

The current price shown for MOREPEN LAB. LTD (MOREPENLAB) on Fincrux is ₹124 with a 52-week high/low of ₹151/33.0.

What is the P/E ratio of MOREPEN LAB. LTD (MOREPENLAB)?

The stock P/E for MOREPEN LAB. LTD (MOREPENLAB) is 61.1 on Fincrux, with ROE at 5.34% and ROCE at 7.65%.

What were MOREPENLAB latest quarterly results?

For Jun 2026, MOREPEN LAB. LTD (MOREPENLAB) reported sales ₹541 Cr and net profit ₹54 Cr (figures in ₹ crore unless noted).

What are MOREPENLAB annual sales and net profit?

For TTM, MOREPEN LAB. LTD (MOREPENLAB) shows sales of ₹1,831 Cr and net profit of ₹112 Cr on the Fincrux profit & loss statement.

Who owns MOREPEN LAB. LTD (MOREPENLAB)?

Latest shareholding for MOREPEN LAB. LTD (MOREPENLAB) on Fincrux: Promoters 35.66% (Sep 2026), FIIs 3.43% (Sep 2026), DIIs 1.70% (Sep 2026), Government 0.01% (Sep 2026), Public 59.19% (Sep 2026).

Where can I find MOREPEN LAB. LTD (MOREPENLAB) financials?

MOREPEN LAB. LTD (MOREPENLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MOREPENLAB balance sheet and cash flow?

Yes. The MOREPEN LAB. LTD (MOREPENLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:58